Literature DB >> 11123020

Initial management of proliferative lupus nephritis: to cytotoxic or not to cytotoxic?

H M Belmont1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 11123020     DOI： 10.1007/s11926-999-0001-9

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  15 in total

1.  Intense immunosuppression and stem cell transplantation or rescue for severe systemic lupus erythematosus.

Authors:  A M Marmont
Journal:  Lupus       Date:  1999       Impact factor: 2.911

2.  Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease.

Authors:  R A Brodsky; M Petri; B D Smith; E J Seifter; J L Spivak; M Styler; C V Dang; I Brodsky; R J Jones
Journal:  Ann Intern Med       Date:  1998-12-15       Impact factor: 25.391

3.  Treatment of lupus nephritis: a meta-analysis of clinical trials.

Authors:  V K Bansal; J A Beto
Journal:  Am J Kidney Dis       Date:  1997-02       Impact factor: 8.860

4.  Successful mycophenolate mofetil treatment of glomerular disease.

Authors:  W A Briggs; M J Choi; P J Scheel
Journal:  Am J Kidney Dis       Date:  1998-02       Impact factor: 8.860

5.  Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis.

Authors:  D T Felson; J Anderson
Journal:  N Engl J Med       Date:  1984-12-13       Impact factor: 91.245

6.  A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.

Authors:  E J Lewis; L G Hunsicker; S P Lan; R D Rohde; J M Lachin
Journal:  N Engl J Med       Date:  1992-05-21       Impact factor: 91.245

7.  Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

Authors:  D T Boumpas; H A Austin; E M Vaughn; J H Klippel; A D Steinberg; C H Yarboro; J E Balow
Journal:  Lancet       Date:  1992-09-26       Impact factor: 79.321

8.  Lupus erythematosus in the 1980s: a survey of 570 patients.

Authors:  M Pistiner; D J Wallace; S Nessim; A L Metzger; J R Klinenberg
Journal:  Semin Arthritis Rheum       Date:  1991-08       Impact factor: 5.532

9.  Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only.

Authors:  A D Steinberg; S C Steinberg
Journal:  Arthritis Rheum       Date:  1991-08

10.  Intermittent intravenous cyclophosphamide therapy for lupus nephritis.

Authors:  T J Lehman; D D Sherry; L Wagner-Weiner; D K McCurdy; H M Emery; D B Magilavy; A Kovalesky
Journal:  J Pediatr       Date:  1989-06       Impact factor: 4.406
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.